Source link : https://www.newshealth.biz/health-news/modified-quadruplet-regimen-effective-in-older-myeloma-patients/
(MedPage Today) — A modified version of the regimen combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with bortezomib (Velcade), lenalidomide (Revlimid), and limited dexamethasone was safe and effective for older multiple myeloma… Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/114075 Author : Publish date : 2025-02-04 20:34:38 Copyright for syndicated content belongs to the linked Source.
Author : News Health
Publish date : 2025-02-04 20:34:38
Copyright for syndicated content belongs to the linked Source.